Immunovant (IMVT) Q2 2025 Earnings

May 29Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.76
-0.68
-0.6
-0.52

Details

Expected EPS
-0.713265
Actual EPS
-0.64
Surprise EPS
0.07
Surprise Percent
+10.27%

Description

⁨Immunovant⁩ (⁦IMVT⁩) has reported earnings of ⁦-0.64⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts